[
    [
        {
            "time": "",
            "orginal_text": "上半年，药企中8位董事长已离职 董监高成员变化",
            "features": {
                "keywords": [
                    "药企",
                    "董事长",
                    "离职",
                    "董监高"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "上半年，药企中8位董事长已离职 董监高成员变化",
            "scores": {
                "Correlation": 8,
                "Sentiment": 2,
                "Importance": 7,
                "Impact": 4,
                "Duration": 2,
                "Entity_Density": 5,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "万泰生物：股东赵义勇减持19万股，减持计划时间已过半",
            "features": {
                "keywords": [
                    "万泰生物",
                    "股东",
                    "赵义勇",
                    "减持"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "万泰生物：股东赵义勇减持19万股，减持计划时间已过半",
            "scores": {
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 5,
                "Duration": 3,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "万泰生物(603392.SH)财务总监赵义勇累计减持18.72万股 减持计划时间已过半",
            "features": {
                "keywords": [
                    "万泰生物",
                    "财务总监",
                    "赵义勇",
                    "减持"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "万泰生物(603392.SH)财务总监赵义勇累计减持18.72万股 减持计划时间已过半",
            "scores": {
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 5,
                "Duration": 3,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "医药生物行业：十四五开启血制品新成长周期 重点推荐天坛生物、博雅生物等",
            "features": {
                "keywords": [
                    "医药生物",
                    "十四五",
                    "血制品",
                    "天坛生物",
                    "博雅生物"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药生物行业：十四五开启血制品新成长周期 重点推荐天坛生物、博雅生物等",
            "scores": {
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "上半年百位药企高管离职，8位为董事长级别",
            "features": {
                "keywords": [
                    "药企",
                    "高管",
                    "离职",
                    "董事长"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "上半年百位药企高管离职，8位为董事长级别",
            "scores": {
                "Correlation": 8,
                "Sentiment": 2,
                "Importance": 7,
                "Impact": 4,
                "Duration": 2,
                "Entity_Density": 5,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]